mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |